巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Spruce Biosciences

    SPRB
    1.380
    0.070
    5.34%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Spruce Biosciences - 延遲價格・最後更新於 26/05 12:14
    最高位
    1.380
    最低位
    1.340
    開市價
    --
    前收市價
    1.310
    成交量(千)
    0.08
    成交額(百萬)
    0.00
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    32.42
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    15.080 - 1.250
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Spruce Biosciences
    證券代碼
    SPRB.US
    所屬板塊
    Biotechnology
    公司業務
    Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
    發行量
    23492873
    公司總部
    2001 Junipero Serra Boulevard, Suite 640
    公司網址
    https://www.sprucebiosciences.com
    公司電郵
    investors@sprucebiosciences.com
    公司電話
    +1 415 655-4168
    暫無內容

    關於

    Spruce Biosciences(SPRB.US)所屬的行業板塊為Biotechnology。
    Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
    詳細公司背景可參考: https://www.sprucebiosciences.com